Association between CHFR methylation and chemosensitivity of paclitaxel in advanced gastric cancer

Medical Oncology

Volumn 31, Issue 4, 2014, Pages

  Wang, Mingming ^a   Shen, Lin ^a   Deng, Dajun ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PACLITAXEL; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; CHFR PROTEIN, HUMAN; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; TUMOR PROTEIN;

ADULT; ADVANCED CANCER; CANCER CHEMOTHERAPY; CHECKPOINT WITH FORKHEAD ASSOCIATED AND RING FINGER GENE; CHEMOSENSITIVITY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SENSITIVITY; GENE; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; METHYLATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; TUMOR BIOPSY; BIOPSY; CHINA; DNA METHYLATION; GENETICS; MIDDLE AGED; STOMACH TUMOR;

ANTINEOPLASTIC AGENTS; BIOPSY; CELL CYCLE PROTEINS; CHINA; CISPLATIN; DEOXYCYTIDINE; DNA METHYLATION; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PACLITAXEL; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84898808294     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0907-6     Document Type: Letter

References (3)

1. Derks S, Cleven AH, Melotte V, Smits KM, Brandes JC, Azad N, van Criekinge W, de Bruïne AP, Herman JG, van Engeland M. Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine. Cancer Metastasis Rev. 2013.
2. Koga Y, Kitajima Y, Miyoshi A, Sato K, Sato S, Miyazaki K. The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer. J Gastroenterol. 2006;41(2):133-9.
3. Yoshida K, Hamai Y, Suzuki T, Sanada Y, Oue N, Yasui W. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer. Anticancer Res. 2006;26(1A):49-54.